Ionetix Corp / DE /

LANSING, MI · CIK 0002108121 · Biotech · Public

Radiopharmaceuticals for diagnostic and therapeutic applications in nuclear medicine

ionetix.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$32M
1 Form D · Apr 2026
5 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$32,331,837
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1993Acelerox, LLC——
1994ViceBio——
1995SENA RESEARCH, INC.——
1996Ionetix Corp / DE /—$32M
1997JYANT, INC.——
1998CERAMIDE THERAPEUTICS, LLC——
1999CLAIRIgene——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Douglas BootheDirector
  • Kevin CameronExecutive Officer
  • David LandskowskyDirector
  • Gregory MartinDirector
  • Phieu PhunExecutive Officer
  • Michael StewartDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.